Celecoxib with its anti-inflammatory and anti-VEGF effects may provide a strong rationale for potential use itself or as an adjunct to currently existing therapies in the proliferative disorders of the eye, such as diabetic retinopathy and AMD. Here, VEGFA is linked to age-related macular degeneration.